SecBot SecBot

ICCM

IceCure Medical Ltd.
Nasdaq· Surgical & Medical Instruments & Apparatus· Inc. L3· CIK 0001584371 Healthcare & Medical Devices
$1.04 +0.03 (+2.97%)
Oct 26 4:00 PM ET · prev $1.01
Market cap
$3.4M
Nano cap
Median target
🔒 Subscribers only
Next earnings
Nov 2
in 7 days · EPS est. −$0.83
1 year
−95.6%
from $23.82 · Oct 27
30 days
−36.2%
from $1.63
52-week range
$1.00–23.82
−96% from high · low Oct 22
Avg volume 20D
191.0K
Oct 6 spike 533.1K
Short interest
52.2K
≈1.5% of shares · −49.2%
Days to cover
1.0
at average volume
Insider net
$0
no open-market trades · 12 mo
Filing reports
20
analyzed by SecBot
SecBot read MIXED 8 reports · 90 days
Balance 2 bearish · 1 bullish · 1 mixed · 4 neutral oldest → newest, height = score
Avg score ·High conf. 6/8 ·Next Earnings date, Nov 2, 2026
Strongest BEARISH IceCure Medical announced that the AMA's CPT Editorial Panel denied its application to transition from a…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersNO TRADES

    No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.

  • EstimatesRISING

    Current-quarter EPS estimate −$0.880 → −$0.830 over 90 days. 0 up, 1 down in 30 days.

  • Short sellersCOVERING

    Short interest −49.2% to 52.2K shares. 1.0 days to cover, ≈1.5% of shares.

  • TrendDOWNTREND

    42% below its 50-day average. New closing low $1.00 on Oct 22.

Who's buying

13F
Top holderSharesValue
JANE STREET GROUP, LLC34,885$169.5K
UBS Group AG17,093$83.1K
HRT FINANCIAL LP15,151$73.0K
JPMORGAN CHASE & CO5,950$31.3K
MORGAN STANLEY4,334$21.1K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

last action May 2026

Fresh Price Targets

Analyst price targets updated within the last 24 hours are for subscribers only.

Subscribe for Full Access
Recent actions
DateFirmActionRating
May 14, 2026Maxim Group
MAINTAIN
MAINTAINBuy
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 2, 2026
Earnings date
ICCM Q3 2026 Earnings Scheduled — 2026-11-02
Recent
Oct 13, 2026
Press release
IceCure Highlights Clinical Data and Strong Physician Engagement for ProSense® Breast Cancer Cryoablation at EUSOBI 2026
Scientific presentations, research posters and clinical workshops featured ProSense® breast cancer cryoablation and highlighted strong physician…
Oct 6, 2026
Press release
IceCure Expands ProSense® ChoICE Study for Low-Risk Breast Cancer adding Legacy Health in Portland, OR as U.S. Clinical Site
CAESAREA, Israel, Oct. 6, 2026 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure," "IceCure Medical" or the "Company"), developer of…
Sep 10, 2026
Press release
IceCure Medical Receives Regulatory Approval to Market ProSense® in China
CAESAREA, Israel, Sept. 10, 2026 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure," "IceCure Medical" or the "Company"), developer of…
Aug 20, 2026
Press release
West Cancer Center Receives IRB Approval to Commence IceCure's ChoICE Study for Breast Cancer Cryoablation
Patients are expected to enroll in the post-marketing study in the coming weeks, following approval from the Institutional Review Board of West…
Aug 12, 2026
Earnings date
ICCM Q2 2026 Earnings Scheduled — 2026-08-12

Insider ledger

Form 4
$0
open-market buys or sells · 12 mo
DateInsiderTypeValue
Aug 14, 2026
Dotan Merav Nir
VP, Human Resources
AWARD73,890 sh
Aug 14, 2026
Peleg Meir
Chief Financial Officer
AWARD181,483 sh
Aug 14, 2026
Levav Shay
Chief Operating Officer
AWARD141,483 sh
Aug 14, 2026
Tel-Tzure Tlalit Bussi
VP, BD & Global Marketing
AWARD101,483 sh
Aug 14, 2026
Good Shad
VP, Sales for North America
AWARD131,483 sh

Earnings setup

Estimates
Nov 2
reports in 7 days
−$0.83
EPS estimate, this quarter
+6%
estimate change, 90 days
0↑ 1↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q-$0.83-$0.83–-$0.83+0.0%$876.5K
Next Q-$0.84-$0.84–-$0.84+0.0%$1.6M
Current FY-$4.61-$4.61–-$4.61+0.0%$4.3M
Next FY-$3.44-$3.71–-$3.00+0.0%$8.8M

Short side

FINRA· Sep 30, 2026
52,159
shares short
-49.2%
vs prior settlement
1.0
days to cover
≈1.5%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 13, 2026 SEC
IceCure Medical issued a press release highlighting ProSense cryoablation presentations and workshops at the EUSOBI…
6-K — Impact 3/10
Oct 13, 2026 Other
IceCure Highlights Clinical Data and Strong Physician Engagement for ProSense® Breast Cancer Cryoablation at EUSOBI 2026
Scientific presentations, research posters and clinical workshops featured ProSense® breast cancer c
Oct 5, 2026 SEC
IceCure Medical filed its proxy statement for the annual and special general meeting on November 2, 2026. The meeting…
6-K — Impact 3/10
Oct 5, 2026 SEC
IceCure Medical announced that the AMA's CPT Editorial Panel denied its application to transition from a temporary…
6-K — Impact 6/10
Aug 14, 2026 Insider
Dotan Merav Nir was granted 73,890 shares
VP, Human Resources
Aug 14, 2026 Insider
Peleg Meir was granted 181,483 shares
Chief Financial Officer
Aug 14, 2026 Insider
Levav Shay was granted 141,483 shares
Chief Operating Officer

SecBot reports

20 filings · 2 bullish · 7 bearish · 2 mixed · 9 neutral
All ICCM filing & press-release reports (20)